11 min listen
Fruquintinib for Refractory Metastatic CRC, Abortion Facility Type and Procedural Complications, Screening for Osteoporosis, and more
Fruquintinib for Refractory Metastatic CRC, Abortion Facility Type and Procedural Complications, Screening for Osteoporosis, and more
ratings:
Length:
8 minutes
Released:
Jun 26, 2018
Format:
Podcast episode
Description
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the June 26, 2018 issue
Released:
Jun 26, 2018
Format:
Podcast episode
Titles in the series (100)
JAMA: 2006-04-12, Vol. 295, No. 14, This Week's Audio Commentary: Audio Commentary by Dr Catherine D. DeAngelis, MD, MPH, Editor in Chief of JAMA, the Journal of the American Medical Association, for the April 12, 2006 issue by JAMA Editors' Summary